Cargando…

The prostate after castration and hormone replacement in a rat model: structural and ultrastructural analysis

PURPOSE: To evaluate if late hormonal replacement is able to recover the prostatic tissue modified by androgenic deprivation. MATERIALS AND METHODS: 24 rats were assigned into a Sham group; an androgen deficient group, submitted to bilateral orchiectomy (Orch); and a group submitted to bilateral orc...

Descripción completa

Detalles Bibliográficos
Autores principales:	Felix-Patrício, Bruno, Miranda, Alexandre F., Medeiros, Jorge L., Gallo, Carla B. M., Gregório, Bianca M., de Souza, Diogo B., Costa, Waldemar S., Sampaio, Francisco J. B.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Sociedade Brasileira de Urologia 2017
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5678530/ https://www.ncbi.nlm.nih.gov/pubmed/28379662 http://dx.doi.org/10.1590/S1677-5538.IBJU.2016.0484

Ejemplares similares

Effects of L-Glutamine oral supplementation on prostate of irradiated rats
por: Pinto, Flavia C. M., et al.
Publicado: (2016)

How to Quantify Penile Corpus Cavernosum Structures with Histomorphometry: Comparison of Two Methods
por: Felix-Patrício, Bruno, et al.
Publicado: (2015)

Effects of comfort food diet on the penile morphology of stressed rats
por: Marchon, Roger G., et al.
Publicado: (2023)

The corpus cavernosum after treatment with dutasteride or finasteride: A histomorphometric study in a benign prostatic hyperplasia rodent model
por: Da Silva, Marcello H A, et al.
Publicado: (2018)

Effects of Vitamin D Restricted Diet Administered during Perinatal and Postnatal Periods on the Penis of Wistar Rats
por: Fernandes-Lima, Flávia, et al.
Publicado: (2018)

Darolutamide For Castration-Resistant Prostate Cancer
por: Bastos, Diogo A, et al.
Publicado: (2019)

Hormonal therapy and chemotherapy in hormone-naive and castration resistant prostate cancer
por: Recine, Federica, et al.
Publicado: (2015)

“Prostate telocytes change their phenotype in response to castration or testosterone replacement”
por: Felisbino, Sérgio Luis, et al.
Publicado: (2019)

Surgical Castration in Hormone-Refractory Metastatic Prostate Cancer Patients Can Be an Alternative for Medical Castration
por: Zaitsu, Masayoshi, et al.
Publicado: (2012)

The changing landscape of hormonal therapy in castration-resistant prostate cancer
por: Dongre, Amol, et al.
Publicado: (2012)

Dissecting the Hormonal Signaling Landscape in Castration-Resistant Prostate Cancer
por: Fontana, Fabrizio, et al.
Publicado: (2021)

Expression of stromal elements of prostatic adenocarcinoma in different gleason scores
por: Osorio, Clarice Fraga Esteves Maciel, et al.
Publicado: (2019)

Immediate and late effects of chronic stress in the testes of prepubertal and adult rats
por: Ribeiro, Carina T, et al.
Publicado: (2018)

Advances in hormonal therapies for hormone naïve and castration-resistant prostate cancers with or without previous chemotherapy
por: Pham, Thy, et al.
Publicado: (2016)

Resveratrol attenuates metabolic, sperm, and testicular changes in adult Wistar rats fed a diet rich in lipids and simple carbohydrates
por: de Oliveira, Fabiana A, et al.
Publicado: (2019)

Metabolic and Testicular Effects of the Long-Term Administration of Different High-Fat Diets in Adult Rats
por: Campos-Silva, Pamella, et al.
Publicado: (2015)

Impact of Time to Castration Resistance on Survival in Metastatic Hormone Sensitive Prostate Cancer Patients in the Era of Combination Therapies
por: Wenzel, Mike, et al.
Publicado: (2021)

Diets Rich in Saturated and Polyunsaturated Fatty Acids Induce Morphological Alterations in the Rat Ventral Prostate
por: Furriel, Angélica, et al.
Publicado: (2014)

Castration for Prostatic Hypertrophy
Publicado: (1899)

Effects of dutasteride and tamsulosin on penile morphology in a rodent model
por: Da Silva, Marcello H. A., et al.
Publicado: (2023)

Exploring anti-androgen therapies in hormone dependent prostate cancer and new therapeutic routes for castration resistant prostate cancer
por: Harris, Anna E., et al.
Publicado: (2022)

The use of luteinizing hormone-releasing hormone analogues is still an indispensable element of therapy in castrate-resistant prostate cancer
por: Milecki, Tomasz, et al.
Publicado: (2014)

Modifications of Erectile Tissue Components in the Penis during the Fetal Period
por: Gallo, Carla B. M., et al.
Publicado: (2014)

Reinduction of Hormone Sensitivity to Goserelin following Chemotherapy with Vinorelbine in Castration-Resistant Prostate Cancer
por: Grenader, Tal, et al.
Publicado: (2010)

Compositional differences of gut microbiome in matched hormone-sensitive and castration-resistant prostate cancer
por: Liu, Yufei, et al.
Publicado: (2020)

Utilization Trends of Novel Hormonal Agents in Metastatic Castration-Resistant Prostate Cancer in Quebec
por: Hu, Jason, et al.
Publicado: (2022)

Testosterone Replacement Therapy Prevents Alterations of Coronary Vascular Reactivity Caused by Hormone Deficiency Induced by Castration
por: Rouver, Wender Nascimento, et al.
Publicado: (2015)

FGFR1, a novel biomarker for metastatic castration-resistant prostate cancer?
por: Gallo, Leandro H.
Publicado: (2021)

Radium-223 for the treatment of castration-resistant prostate cancer
por: El-Amm, Joelle, et al.
Publicado: (2015)

Morphological and functional alterations of the prostate tissue during clinical progression in hormonally-naïve, hormonally-treated and castration-resistant patients with metastatic prostate cancer
por: Korček, Michal, et al.
Publicado: (2020)

Effects of chronic restraint stress in the prostate of prepubertal and adult rats
por: Procópio, Isabella Mendes, et al.
Publicado: (2023)

Prostatic Neoplasia in the Intact and Castrated Dog: How Dangerous is Castration?
por: Schrank, Magdalena, et al.
Publicado: (2020)

Castration for Hypertrophy of the Prostate Gland
Publicado: (1895)

Effect of a high-fat diet on the rat bladder wall and bioactive action of Brazil nut oil
por: de Souza, Aline Costa, et al.
Publicado: (2019)

Upregulated FGFR1 expression is associated with the transition of hormone-naive to castrate-resistant prostate cancer
por: Armstrong, K, et al.
Publicado: (2011)

New therapies for relapsed castration-resistant prostate cancer based on peptide analogs of hypothalamic hormones
por: Schally, Andrew V, et al.
Publicado: (2015)

Bruceantin targets HSP90 to overcome resistance to hormone therapy in castration-resistant prostate cancer
por: Moon, Sue Jin, et al.
Publicado: (2021)

Comparison of docetaxel pharmacokinetics between castration-resistant and hormone-sensitive metastatic prostate cancer patients
por: Vermunt, Marit A. C., et al.
Publicado: (2022)

Visceral Metastasis Predicts Response to New Hormonal Agents in Metastatic Castration-Sensitive Prostate Cancer
por: Yekedüz, Emre, et al.
Publicado: (2023)

Castration-Resistant Prostate Cancer: Mechanisms, Targets, and Treatment
por: Amaral, Teresa Maria Santos, et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_a7bcr052dn0d4md0ljt1pr49aj